Related Experiment Video

Updated: May 20, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3

Jiajie Hou1, Juan Xu, Runqiu Jiang

  • 1Liver Transplantation Center of First Affiliated Hospital and State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.

Hepatology (Baltimore, Md.)
|July 24, 2012
PubMed
Abstract

Insights

Protein tyrosine phosphatase receptor type O (PTPRO) acts as a tumor suppressor in hepatocellular carcinoma (HCC). Its reduced expression, linked to estrogen receptor alpha (ERα), promotes HCC progression by upregulating STAT3 signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein tyrosine phosphatase receptor type O (PTPRO) is recognized as a tumor suppressor in multiple cancer types.
  • The specific role and regulatory mechanisms of PTPRO in hepatocellular carcinoma (HCC) remain to be fully elucidated.

Purpose of the Study:

  • To investigate the function of PTPRO in hepatocellular carcinoma (HCC).
  • To explore the relationship between PTPRO expression, estrogen receptor alpha (ERα), and HCC development.
  • To determine the molecular pathways through which PTPRO exerts its effects in HCC.

Main Methods:

  • Analysis of PTPRO expression levels in 180 pairs of clinical HCC specimens (120 male, 60 female) compared to adjacent tissues.
  • In vitro studies involving PTPRO-transduced HCC cell lines to assess effects on proliferation and apoptosis.
  • In vivo studies using ptpro(-/-) mice to evaluate tumor development.
  • Investigation of ERα's role in regulating PTPRO expression.
  • Analysis of PTPRO's impact on JAK2/PI3K/STAT3 signaling pathways.

Main Results:

  • PTPRO levels were significantly reduced in HCC tissues compared to adjacent tissues, with lower levels observed in male HCC patients.
  • Estrogen receptor alpha (ERα) was identified as a transcription factor that up-regulates PTPRO expression.
  • Overexpression of PTPRO in HCC cell lines inhibited proliferation and promoted apoptosis.
  • Loss of PTPRO in mice led to increased tumor number and size.
  • PTPRO was demonstrated to down-regulate Signal Transducers and Activators of Transcription (STAT3) activity by dephosphorylating Janus Kinase 2 (JAK2) and Phosphoinositide 3-Kinase (PI3K).

Conclusions:

  • PTPRO deficiency contributes to pathological characteristics and gender disparity in HCC, potentially mediated by ERα regulation.
  • The tumor-suppressive function of PTPRO in HCC is linked to the inactivation of STAT3 signaling.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...